Walf-Vorderwülbecke et al. have profiled c-MYB gene expression in MLL-rearranged AML and identified anthelmintic MBZ as a top hit to target c-MYB through screening of the Connectivity Map database [38]. Here, KMT2A is linked to acute myeloid leukemia.